These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16608394)
21. The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan. Granot T; Meruelo D Cancer Gene Ther; 2012 Aug; 19(8):588-91. PubMed ID: 22677940 [TBL] [Abstract][Full Text] [Related]
30. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Akbulut H; Zhang L; Tang Y; Deisseroth A Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708 [TBL] [Abstract][Full Text] [Related]
33. Systemic gene therapy by Sindbis vectors: A potentially safe and effective targeted therapy for identifying and killing tumor cells in vivo. Meruelo D Discov Med; 2004 Feb; 4(20):54-7. PubMed ID: 20705022 [TBL] [Abstract][Full Text] [Related]
34. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy. Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580 [TBL] [Abstract][Full Text] [Related]
35. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene]. Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of a Sindbis virus vector displaying an immunoglobulin-binding domain: antibody-dependent infection of neurons in living mice. Konno A; Honjo T; Uchida A; Ishizuka T; Yawo H Neurosci Res; 2011 Dec; 71(4):328-34. PubMed ID: 21925217 [TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of recombinant alphaviruses as vectors in gene therapy. Wahlfors JJ; Zullo SA; Loimas S; Nelson DM; Morgan RA Gene Ther; 2000 Mar; 7(6):472-80. PubMed ID: 10757020 [TBL] [Abstract][Full Text] [Related]
39. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877 [TBL] [Abstract][Full Text] [Related]
40. Properties of Sindbis virus vectors produced with a chimeric split helper system. Ketola A; Schlesinger S; Wahlfors J Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]